Diagnostic and Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomography for Recurrent Head and Neck Squamous Cell Carcinoma
- 15 October 2002
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (20), 4199-4208
- https://doi.org/10.1200/jco.2002.02.590
Abstract
PURPOSE: Patients with recurrent head and neck squamous cell carcinoma (HNSCC) present a diagnostic and therapeutic challenge. We evaluated the diagnostic accuracy and prognostic value of [18F]fluo...This publication has 14 references indexed in Scilit:
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Serial positron emission tomography scans following radiation therapy of patients with head and neck cancerHead & Neck, 2001
- Positron Emission Tomography With Fluorodeoxyglucose for Suspected Head and Neck Tumor Recurrence in the Symptomatic PatientThe Laryngoscope, 2000
- Positron emission tomography provides molecular imaging of biological processesProceedings of the National Academy of Sciences of the United States of America, 2000
- Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancerEuropean Journal of Cancer, 2000
- Surveillance for Recurrent Head and Neck Cancer Using Positron Emission TomographyJournal of Clinical Oncology, 2000
- The detection of local recurrent head and neck cancer with fluroine-18 fluorodeoxyglucose dual-head positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2‐18f‐fluoro‐2‐deoxy‐D‐glucose positron emission tomographyThe Laryngoscope, 1999
- Head and Neck CancerThe New England Journal of Medicine, 1993
- Enzymology of Cancer CellsThe New England Journal of Medicine, 1977